AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Prevention of Postoperative Complications by Negative Pressure Therapy After Complex Breast Cancer Surgery

RecruitingNAAges 18 Years - anyFemaleInstitut du Cancer de Montpellier - Val d'Aurelle
💬

In plain words

What the trial is, and whether it could suit you

There is little scientific data concerning the use of negative pressure therapy after immediate breast reconstruction. That strategy of treatment-reconstruction has expanded increasingly since the last years. The current literature reports only 3 studies on the use of preventive negative pressure therapy in oncologic breast surgery. Moreover, all three are retrospective, case-control studies with serious limitations. The largest published series reports a reduction in the overall complication rate from 15.9% to 8.5%, and a significant reduction in several criteria: infection, scar dehiscence and necrosis. However, the study presents significant biases, with non-comparable populations in terms of comorbidities, surgical procedure performed, inclusion periods (and therefore experience in performing oncological surgery). There was also a high probability of under-assessment or postpone

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: 1. Female ≥ 18 years 2. Patient with unilateral invasive or in situ breast carcinoma 3. Patient with or without neoadjuvant treatment 4. Patient presenting an indication for complex breast surgery by mastectomy with immediate breast reconstruction by implant or oncoplasty by T-shaped mammoplasty. 5. Patient presenting at least one of the following risk factors for scarring disorders: * Obesity with Body Mass Index BMI ≥ 30 and/or Cup size ≥ E * Active smoking or smoking cessation for less than one month * Diabetes * History of homolateral breast radiotherapy * Long-term corticosteroid therapy 6. Patient to have signed informed consent prior to study entry 7. Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests and other study procedures. 8. Patient affiliated with a health insurance plan. Exclusion Criteria: 1. Legal incapacity or limited legal capacity. Medical or psychological conditions preventing the patient from completing the study or signing the consent form. 2. Pregnant or breast-feeding patient as determined in medical records as part of standard patients care and follow-up 3. Patient under guardianship or safeguard of justice 4. Patient participating in an interventional study with the objective of wound healing 5. Any concurrent or planned surgical procedure on the contralateral breast
💊

What it tests

  • Negative pressure therapy (NPT)
  • Dressing
📍

Where

7 sites
Centre Georges-François Leclerc
Dijon, France
Centre Hospitalier de Nîmes
Nîmes, France
Institut Bergonié
Bordeaux, France
Centre Hospitalier de Montpellier
Montpellier, France
Institut régional du Cancer de Montpellier
Montpellier, France
Institut de Cancérologie de l'Ouest
Angers, France
Centre Léon Bérard
Lyon, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy